BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31018948)

  • 21. AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patients.
    Alpermann T; Haferlach C; Eder C; Nadarajah N; Meggendorfer M; Kern W; Haferlach T; Schnittger S
    Leuk Res; 2015 Mar; 39(3):265-72. PubMed ID: 25592059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute myeloid leukemia with concomitant trisomies 4 and 10: a distinctive form of myeloid leukemia?
    Wong KF; So CC
    Cancer Genet Cytogenet; 2001 May; 127(1):74-6. PubMed ID: 11408070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22)].
    Gritsaev SV; Martynkevich IS; Ziuzgin IS; Kariagina EV; Martynenko LS; Petrova EV; Tsybakova NIu; Ivanova MP; Kostroma II; Tiranova SA; Potikhonova NA; Abdulkadyrov KM
    Ter Arkh; 2014; 86(7):45-52. PubMed ID: 25314777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification.
    de Noronha TR; Mitne-Neto M; Chauffaille ML
    J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genetic abnormalities in AML].
    Nakajima H
    Rinsho Ketsueki; 2019; 60(6):584-593. PubMed ID: 31281149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trisomy 4: a specific karyotype anomaly in primary and secondary acute myeloid leukemia.
    Weber E; Nowotny H; Haas OA; Kasparu H; Grois N; Lutz D
    Leukemia; 1990 Mar; 4(3):219-21. PubMed ID: 2179639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
    Thol F; Damm F; Lüdeking A; Winschel C; Wagner K; Morgan M; Yun H; Göhring G; Schlegelberger B; Hoelzer D; Lübbert M; Kanz L; Fiedler W; Kirchner H; Heil G; Krauter J; Ganser A; Heuser M
    J Clin Oncol; 2011 Jul; 29(21):2889-96. PubMed ID: 21670448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex translocation (6;21;8), a variant of t(8;21), with trisomy 4 in a patient with acute myelogenous leukemia (M2).
    Shinagawa A; Komatsu T; Ninomiya H
    Cancer Genet Cytogenet; 1999 Feb; 109(1):72-5. PubMed ID: 9973964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.
    Xu W; Zhou HF; Fan L; Qian SX; Chen LJ; Qiu HR; Zhang SJ; Li JY
    Onkologie; 2008 Sep; 31(8-9):440-4. PubMed ID: 18787351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated trisomy 10 in an infant with acute myeloid leukemia: a case report and review of literature.
    Yuan J; McDonough C; Kulharya A; Ramalingam P; Manaloor E
    Int J Clin Exp Pathol; 2010 Aug; 3(7):718-22. PubMed ID: 20830243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trisomy 4 as the sole karyotypic abnormality in a case of acute biphenotypic leukemia with T-lineage markers in minimally differentiated acute myelocytic leukemia.
    Al-Qurashi FH; Owaidah T; Iqbal MA; Aljurf M
    Cancer Genet Cytogenet; 2004 Apr; 150(1):66-9. PubMed ID: 15041226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtype-specific patterns of molecular mutations in acute myeloid leukemia.
    Rose D; Haferlach T; Schnittger S; Perglerová K; Kern W; Haferlach C
    Leukemia; 2017 Jan; 31(1):11-17. PubMed ID: 27285584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO-AML study.
    Laursen AC; Sandahl JD; Kjeldsen E; Abrahamsson J; Asdahl P; Ha SY; Heldrup J; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Forestier E; Hasle H
    Genes Chromosomes Cancer; 2016 Sep; 55(9):719-26. PubMed ID: 27153159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemia.
    Gupta V; Minden MD; Yi QL; Brandwein J; Chun K
    Leuk Res; 2003 Nov; 27(11):983-91. PubMed ID: 12859991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of class I and II aberrations in Iraqi childhood acute myeloid leukemia using filter paper cards.
    Al-Kzayer LF; Uyen le TN; Al-Jadiry MF; Al-Hadad SA; Al-Badri SA; Ghali HH; Ameen NA; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Al-Ani MH; Saber PA; Khalil HM; Inoshita T; Kamata M; Koike K; Sakashita K
    Ann Hematol; 2014 Jun; 93(6):949-55. PubMed ID: 24464319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tandem duplication of the MLL gene in myelodysplastic syndrome-derived overt leukemia with trisomy 11.
    Yamamoto K; Hamaguchi H; Nagata K; Kobayashi M; Taniwaki M
    Am J Hematol; 1997 May; 55(1):41-5. PubMed ID: 9136917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is trisomy 4 a secondary chromosomal abnormality in acute myeloblastic leukemia?
    Bonomi R; Le Coniat M; Berger R
    Cancer Genet Cytogenet; 1995 Feb; 79(2):186-7. PubMed ID: 7889518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
    Renneville A; Boissel N; Nibourel O; Berthon C; Helevaut N; Gardin C; Cayuela JM; Hayette S; Reman O; Contentin N; Bordessoule D; Pautas C; Botton Sd; Revel Td; Terre C; Fenaux P; Thomas X; Castaigne S; Dombret H; Preudhomme C
    Leukemia; 2012 Jun; 26(6):1247-54. PubMed ID: 22289988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.
    Rezaei N; Arandi N; Valibeigi B; Haghpanah S; Khansalar M; Ramzi M
    Turk J Haematol; 2017 Dec; 34(4):300-306. PubMed ID: 28294102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia.
    Wang X; Dai H; Wang Q; Wang Q; Xu Y; Wang Y; Sun A; Ruan J; Chen S; Wu D
    PLoS One; 2013; 8(4):e61341. PubMed ID: 23613835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.